Overall (n=1556) | Male (n=813) | Female (n=743) | P value | White (n=827) | Asian (n=177) | Black (n=122) | Hispanic (n=277) | P value | |
ANA (n=1461) | 21.8% | 18.1% | 25.9% | <0.001 | 20.2% | 21.4% | 28.3% | 20.8% | 0.30 |
ASMA (n=483) | 13.3% | 11.9% | 14.6% | 0.38 | 11.4% | 16.1% | 10.5% | 18.4% | 0.30 |
AMA (n=505) | 2.2% | 2.4% | 2.0% | 0.78 | 1.2% | 5.8% | 2.4% | 1.8% | 0.19 |
LKM (n=86) | 1.2% | 0% | 2.0% | 0.39 | 2.1% | 0% | 0% | 0% | 0.86 |
ANA, antinuclear antibody; AMA, antimitochondrial antibody; ASMA, antismooth muscle antibody; LKM, anti-liver kidney microsomal antibody.